MARLENE DEBEL - 28 Feb 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Stephen W. Gauster, Authorized Signer
Issuer symbol
MET
Transactions as of
28 Feb 2023
Net transactions value
-$1,212,213
Form type
4
Filing time
02 Mar 2023, 17:55:03 UTC
Previous filing
27 Feb 2023
Next filing
11 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +5,542 +10% 60,841 28 Feb 2023 Direct F1
transaction MET Common Stock Award +32,193 +53% 93,034 28 Feb 2023 Direct F2
transaction MET Common Stock Tax liability $1,030,617 -14,368 -15% $71.73 78,666 28 Feb 2023 Direct F3
transaction MET Common Stock Tax liability $181,596 -2,548 -3.2% $71.27 76,118 01 Mar 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Award $0 +16,625 $0.000000 16,625 28 Feb 2023 Common Stock 16,625 $71.73 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2 Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F3 Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F4 Withheld for taxes on shares issued for restricted stock units.
F5 The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.